The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

BACKGROUND: Glioblastoma patients show a great variability in progression free survival (PFS) and overall survival (OS). To gain additional pretherapeutic information, we explored the potential of O-(2-(18)F-fluoroethyl)-L-tyrosine (FET) PET as an independent prognostic biomarker. METHODS: We retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Poulsen, Sidsel Højklint, Urup, Thomas, Grunnet, Kirsten, Christensen, Ib Jarle, Larsen, Vibeke Andrée, Jensen, Michael Lundemann, af Rosenschöld, Per Munck, Poulsen, Hans Skovgaard, Law, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5281673/
https://www.ncbi.nlm.nih.gov/pubmed/27554774
http://dx.doi.org/10.1007/s00259-016-3494-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5281673/
https://www.ncbi.nlm.nih.gov/pubmed/27554774
http://dx.doi.org/10.1007/s00259-016-3494-2

Ejemplares similares